Resistance and progression mechanisms in prostate cancer
PRINCIPAL INVESTIGATORS
- Mireia Olivan Riera
CLINICAL RESEARCHERS
- Manuel Maria Castells Esteve
- Maria Pane Foix
- Natàlia Picola Brau
- Jose Francisco Suarez Novo
POSTDOCTORAL RESEARCHERS
- Andrea Alegre Marti
- Alba Jimenez Panizo
- Ana Sofia Semiao Correia Da Rocha
PREDOCTORAL RESEARCHERS
- Pilar Salamanca Jimenez
- Javier Sigüenza Andrade
SCIENTIFIC SUPPORT
- Roderic Espin Garcia
- Nadia García Lozano
- Ines Gonzalez Vazquez
Cancer
Oncobell
Scientific production
13
PAPERS
Average IF: 3,39
1
LED PAPER
Average IF: 2,5
1 PUBLICATION IN FIRST DECILE
4 PUBLICATIONS IN FIRST QUARTILE
8 PUBLICATIONS IN FIRST QUARTILE
Selected publications
- Iagaru,A;Suarez,JF;Behr,S;Aggarwal,R;Paredes,P;Buffi,N;Penhoat,T et al, Imaging Efficacy of [(18)F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study., J Nucl Med, 2025;124(8):1232-1238, doi:10.2967/jnumed.124.269007
- Ferre Giraldo,A;Castells,M;Madurga,A;Arbiol Roca,A;de Rocco Ponce,M;Bassas,L;Vigues,F et al, Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer, Int. J. Mol. Sci., 2025;26(19):doi:10.3390/ijms26199562
- Zamora,V;Garin,O;Suárez,JF;Guedea,F;Pont,À;Pardo,Y;Goñi,A et al, Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer., Eur Urol Open Sci, 2025;82160-167, doi:10.1016/j.euros.2025.10.007
- Morote,J;Miro,B;Hernando,P;Paesano,N;Picola,N;Muñoz Rodriguez,J;Ruiz Plazas,X et al, Developing a Predictive Model for Significant Prostate Cancer Detection in Prostatic Biopsies from Seven Clinical Variables: Is Machine Learning Superior to Logistic Regression?, Cancers, 2025;17(7):doi:10.3390/cancers17071101
- Paesano,N;Picola,N;Muñoz Rodriguez,J;Ruiz Plazas,X;Muñoz Rivero,MV;Celma,A;García de Manuel,G et al, Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired-Matched Study., Diagnostics (Basel), 2025;15(3):doi:10.3390/diagnostics15030288
Research highlights
PROJECTS
1 Granted competitive project
9 Ongoing competitive projects
3 Ongoing clinical trials
1 Started non competitive project
1 Ongoing non competitive project
NETWORKS
AGAUR – SGR
Selected projects
- PC210340. Dissecting the role of cancer cell chromatin remodeling on the landscape of tumor immune microenvironment.. DEPARTMENT OF DEFENSE. Budget: 465.431,26€. 2022-2026. PI: ALVARO AYTES MENESES.
- LABAE211710AYTE. Dissecting EZH2-SWI/SNF antagonism to target cell plasticity in therapy resistant prostate cancer. Asociación Española Contra el Cáncer (AECC). Budget: 299.363,42€. 2021-2025. PI: ALVARO AYTES MENESES.
- CPP2024-011416. Desarrollo de nuevas terapias contra el cáncer basadas en la inhibición de MAO-A_ONCOMAO. Ministerio de Ciencia e Innovación. Budget: 286.099,40€. 2025-2028. PI: ALVARO AYTES MENESES.
- PI23/00513. Inhibición de la señalización mediada por ROS para superar la resitencia a antiandrógenos e immunoterápia en cáncer de próstata resistente a la castración. Instituto de Salud Carlos III (ISCIII). Budget: 233.750€. 2024-2026. PI: ALVARO AYTES MENESES.
- CNS2023-145615. Impacto del pérdida de Brca2 en la plasticidad de linaje y la resistencia a la castración en cámcer de próstata. Ministerio de Ciencia e Innovación. Budget: 199.922€. 2024-2026. PI: ALVARO AYTES MENESES.